Neostigmine Methylsulfate Injection
Product Images NDC 0641-6265

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 0641-6265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Neostigmine Methylsulfate Injection Usp Anda N 1)

Chemical structure diagram of Neostigmine Methylsulfate, depicting its molecular components and bonds.*

FDA Label Image

462-938-00 (Neostigmine Methylsulfate Injection Usp Anda N 2)

Label for Neostigmine Methylsulfate Injection, USP, 0.5 mg/mL strength, supplied as 5 mg per 10 mL in a vial. The label indicates it is for intravenous use, multiple dose vial, Rx only, and manufactured by Hikma Pharmaceuticals USA Inc. It includes storage instructions and inactive ingredients.*

FDA Label Image

Shelfpack (Neostigmine Methylsulfate Injection Usp Anda N 3)

Neostigmine Methylsulfate Injection, USP label for 5 mg per 10 mL (0.5 mg/mL) intravenous injection, manufactured by Hikma Pharmaceuticals USA Inc. The label includes storage instructions, contents description, and the NDC 0641-6264-10 for a 10 x 10 mL multiple dose vial pack. It highlights that this product is Rx only and contains preservatives and excipients.*

FDA Label Image

462-940-00 (Neostigmine Methylsulfate Injection Usp Anda N 4)

Label for Neostigmine Methylsulfate Injection, USP 1 mg/mL (10 mg per 10 mL) by Hikma Pharmaceuticals USA Inc. It indicates intravenous use and a 10 mL multiple dose vial. The label includes formulation details, storage instructions, and a barcode, along with the NDC 0641-6265-01 and the novaplus logo.*

FDA Label Image

Shelfpack (Neostigmine Methylsulfate Injection Usp Anda N 5)

The image shows a label for Neostigmine Methylsulfate Injection, USP by Hikma Pharmaceuticals USA Inc. It is for intravenous use, with a strength of 10 mg per 10 mL (1 mg/mL). The label includes NDC 0641-6265-10 and storage instructions, emphasizing multiple dose vials and protection from light.*

FDA Label Image

Layout 1 (Neostigmine Methylsulfate Injection Usp Anda N 6)

A small rectangular medication label featuring a QR code on the left and printed alphanumeric codes on the right including GTIN, Serial Number (SN), Expiration Date (EXP), and Lot Number (LOT). No proprietary name or strength is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.